Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.

Published byBrian Nickolas Underwood Modified over 6 years ago

Similar presentations

Presentation on theme: "Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen."— Presentation transcript:

1 Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen Booth, MB, Neil Wrightson, BS, Javier Castrodeza, MD, Jerome Jungschleger, MD, Nicola Robinson-Smith, BA, Andrew Woods, BA, Gareth Parry, FRCP, Stephan Schueler, MD, Guy A. MacGowan, MD, FACC  The Journal of Heart and Lung Transplantation  Volume 36, Issue 1, Pages (January 2017) DOI: /j.healun Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

2 Figure 1 Kaplan-Meier survival curves for aortic valve opening (AVO) in the (A) entire cohort and (B) in the 30-days-out cohort. LVAD, left ventricular assist device. The Journal of Heart and Lung Transplantation  , 42-49DOI: ( /j.healun ) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

3 Figure 2 Kaplan-Meier survival curves. (A) Aortic valve opening (AVO) and combined event-free survival. (B) AVO and pump thromobisis (PT)-free survival. LVAD, left ventricular assist device. The Journal of Heart and Lung Transplantation  , 42-49DOI: ( /j.healun ) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Download ppt "Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen."

Similar presentations

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
Jennifer A. Cowger, MD, Matthew A

Jennifer A. Cowger, MD, Matthew A
The Journal of Heart and Lung Transplantation

The Journal of Heart and Lung Transplantation
Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.
Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,

Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.

Similar presentations

Ads by Google